The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo

Abstract The CBFβ subunit is the non-DNA-binding subunit of the heterodimeric core-binding factor (CBF). CBFβ associates with DNA-binding CBFα subunits and increases their affinity for DNA. Genes encoding the CBFβ subunit ( CBFB ) and one of the CBFα subunits ( CBFA2 , otherwise known as AML1 ) are the most frequent targets of chromosomal translocations in acute leukemias in humans. We and others previously demonstrated that homozygous disruption of the mouse Cbfa2 ( AML1 ) gene results in embryonic lethality at midgestation due to hemorrhaging in the central nervous system and blocks fetal liver hematopoiesis. Here we demonstrate that homozygous mutation of the Cbfb gene results in the same phenotype. Our results demonstrate that the CBFβ subunit is required for CBFα2 function in vivo.

[1]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Rowley,et al.  Associations between morphology, karyotype, and clinical features in myeloid leukemias. , 1987, Human pathology.

[3]  Stuart H. Orkin,et al.  Transcription Factors and Hematopoietic Development (*) , 1995, The Journal of Biological Chemistry.

[4]  C. Eaves,et al.  Properties of the earliest clonogenic hemopoietic precursors to appear in the developing murine yolk sac. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Shurtleff,et al.  Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. , 1995, Blood.

[6]  J. Li,et al.  The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[8]  Yoshiaki Ito,et al.  Molecular Cloning and Characterization of PEBP2β, the Heterodimeric Partner of a Novel Drosophila runt-Related DNA Binding Protein PEBP2α , 1993 .

[9]  Y. Ito,et al.  Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer , 1990, Journal of virology.

[10]  I. Bar-Am,et al.  A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. , 1996, DNA and cell biology.

[11]  T. Grundström,et al.  Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences , 1991, Journal of virology.

[12]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[13]  J. Rowley,et al.  The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Wijmenga,et al.  Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 , 1996, Cell.

[15]  N. Speck,et al.  A new transcription factor family associated with human leukemias. , 1995, Critical reviews in eukaryotic gene expression.

[16]  S. Orkin,et al.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 , 1991, Nature.

[17]  S. Coughlin,et al.  Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. , 1994, The American journal of pathology.

[18]  B. Graves,et al.  Characterization of the cooperative function of inhibitory sequences in Ets-1 , 1996, Molecular and cellular biology.

[19]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[20]  James Douglas Engel,et al.  Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis , 1995, Nature Genetics.

[21]  Y. Ito,et al.  PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Gergen,et al.  Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt , 1996, Molecular and cellular biology.

[24]  A. Simeone,et al.  Expression of runt in the mouse embryo , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  N. Speck,et al.  Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. , 1992, Molecular and cellular biology.

[26]  R. Weinberg,et al.  Extensive contribution of Rb‐deficient cells to adult chimeric mice with limited histopathological consequences. , 1994, The EMBO journal.

[27]  J. Seidman,et al.  Production of homozygous mutant ES cells with a single targeting construct , 1992, Molecular and cellular biology.

[28]  M. Moore,et al.  Ontogeny of the Haemopoietic System: Yolk Sac Origin of In Vivo and In Vitro Colony Forming Cells in the Developing Mouse Embryo * , 1970, British journal of haematology.

[29]  Yoshiaki Ito,et al.  Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain , 1995 .

[30]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[31]  D. Wilkinson.  In situ hybridization: a practical approach , 1998 .

[32]  Y. Yamaguchi-Iwai,et al.  Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development , 1995, Molecular and cellular biology.

[33]  D. Le Paslier,et al.  The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. , 1995, Blood.

[34]  J U Bowie,et al.  Identification of C-terminal extensions that protect proteins from intracellular proteolysis. , 1989, The Journal of biological chemistry.

[35]  I. Bar-Am,et al.  AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. , 1994, Genomics.

[36]  R. Beddington,et al.  Whole-mount in situ hybridization in the mouse embryo: gene expression in three dimensions. , 1993, Trends in genetics : TIG.

[37]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Stuart H. Orkin,et al.  An early haematopoietic defect in mice lacking the transcription factor GATA-2 , 1994, Nature.

[39]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[40]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[41]  M. Marín‐padilla.  Early vascularization of the embryonic cerebral cortex: Golgi and electron microscopic studies , 1985, The Journal of comparative neurology.

[42]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[43]  N. Speck,et al.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor , 1993, Molecular and cellular biology.

[44]  Y. Yamaguchi-Iwai,et al.  Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. , 1993, Oncogene.

[45]  M. Ashburner.  A Laboratory manual , 1989 .